- Home
- GROW vs EVAX Comparison
GROW vs EVAX Comparison
Compare GROW & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GROW | EVAX |
|---|---|---|
| Founded | 1968 | 2008 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.3M | 33.4M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | GROW | EVAX |
|---|---|---|
| Price | $3.25 | $3.15 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $12.33 |
| AVG Volume (30 Days) | ★ 129.8K | 76.2K |
| Earning Date | 11-13-2025 | 03-31-2026 |
| Dividend Yield | ★ 2.76% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.07 | N/A |
| Revenue | ★ $8,546,000.00 | $7,650,000.00 |
| Revenue This Year | N/A | $128.77 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $49.99 | ★ N/A |
| Revenue Growth | N/A | ★ 132.17 |
| 52 Week Low | $2.02 | $1.20 |
| 52 Week High | $3.65 | $12.15 |
Technical Indicators
Market Signals| Indicator | GROW | EVAX |
|---|---|---|
| Relative Strength Index (RSI) | 64.92 | 35.66 |
| Support Level | $2.88 | $3.06 |
| Resistance Level | $3.33 | $3.66 |
| Average True Range (ATR) | 0.18 | 0.33 |
| MACD | -0.01 | 0.04 |
| Stochastic Oscillator | 48.05 | 22.29 |
Price Performance
Historical ComparisonAbout GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.
About EVAX Evaxion Biotech
Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.